Clinical and laboratory manifestations of anti-factor V antibodies

被引：64

作者：

Ortel, TL

机构：

[1] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA

来源：

JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1999年 / 133卷 / 04期

关键词：

D O I：

10.1016/S0022-2143(99)90062-8

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：326 / 334

页数：9

共 96 条

[1] FIBRIN SEALANT - SUMMARY OF A CONFERENCE ON CHARACTERISTICS AND CLINICAL USES [J].

ALVING, BM ;

WEINSTEIN, MJ ;

FINLAYSON, JS ;

MENITOVE, JE ;

FRATANTONI, JC .

TRANSFUSION, 1995, 35 (09) :783-790

[2]

ANNAMALAI AE, 1987, BLOOD, V70, P139

[3]

ARVIEUX J, 1997, THROMB HAEMOST S, V78, P331

[4]

BALLESTER OF, 1990, BLOOD S1, V76, pA411

[5]

BANNINGER H, 1993, BRIT J HAEMATOL, V85, P528

[6]

BERRUYER M, 1993, J THORAC CARDIOV SUR, V105, P892

[7]

BRANDT JT, 1986, ARCH PATHOL LAB MED, V110, P224

[8]

Brickner LA, 1996, AM J HEMATOL, V52, P332, DOI 10.1002/(SICI)1096-8652(199608)52:4<332::AID-AJH22>3.0.CO

[9]

2-E

[10] FACTOR-V INHIBITOR AND BULLOUS PEMPHIGOID [J].

BRYNING, K ;

LESLIE, J .

BRITISH MEDICAL JOURNAL, 1977, 2 (6088) :677-678

← 1 2 3 4 5 6 7 8 9 10 →